Short-Course Versus Long-Course Colistin for Treatment of Carbapenem-Resistant A.baumannii in Cancer Patient
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Short-Course Versus Long-Course Colistin for Treatment of Carbapenem-Resistant A.baumannii in Cancer Patient
Authors
Keywords
-
Journal
Antibiotics-Basel
Volume 10, Issue 5, Pages 484
Publisher
MDPI AG
Online
2021-04-23
DOI
10.3390/antibiotics10050484
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Efficacy and Nephrotoxicity of Colistin Alone versus Colistin Plus Vancomycin in Critically Ill Patients Infected with Carbapenem-Resistant Acinetobacter baumannii: A Propensity Score-Matched Analysis
- (2021) Wasan Katip et al. Pharmaceutics
- The effectiveness and nephrotoxicity of loading dose colistin combined with or without meropenem for the treatment of carbapenem-resistant A. baumannii
- (2020) Wasan Katip et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Short- versus long-course therapy in gram-negative bacilli bloodstream infections
- (2019) Adrian Sousa et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Antibiotic treatment duration for bacteremia due to Enterobacteriaceae: A systematic review and meta-analysis
- (2019) Giannoula S. Tansarli et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Short vs. long duration antimicrobial treatment for community-onset bacteremia: A propensity-score matching study
- (2019) Ching-Chi Lee et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Tracing the dissemination of the international clones of multi-drug-resistant Acinetobacter baumannii among cancer patients in Egypt using the PCR-based open reading frame typing (POT) method
- (2019) Miran Y. El Far et al. Journal of Global Antimicrobial Resistance
- New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections
- (2018) Burcu Isler et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Optimal duration of antibiotic treatment in Gram-negative infections
- (2018) Jan J. De Waele et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Changes in the early mortality of adult patients with carbapenem-resistant Acinetobacter baumannii bacteremia during 11 years at an academic medical center
- (2018) Seong-Ho Choi et al. JOURNAL OF INFECTION AND CHEMOTHERAPY
- Colistin Monotherapy Versus Colistin and Rifampin Combination Therapy in Pneumonia Caused by Colistin-resistant Acinetobacter baumannii: A Randomized Controlled Trial
- (2018) Hye Jung Park et al. Journal of Global Antimicrobial Resistance
- Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections
- (2017) Avery N. Nelson et al. INFECTION
- Association of Adverse Events With Antibiotic Use in Hospitalized Patients
- (2017) Pranita D. Tamma et al. JAMA Internal Medicine
- Executive Summary: Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society
- (2016) Andre C. Kalil et al. CLINICAL INFECTIOUS DISEASES
- High-dose colistin for microbiologically documented serious respiratory infections associated with carbapenem-resistantAcinetobacter baummanniiin critically ill cancer patients: a retrospective cohort study
- (2015) Lama H. Nazer et al. Infectious Diseases
- Antibiotic-Resistant Gram-Negative Bacterial Infections in Patients With Cancer
- (2014) Federico Perez et al. CLINICAL INFECTIOUS DISEASES
- Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches
- (2014) Ilias Karaiskos et al. EXPERT OPINION ON PHARMACOTHERAPY
- Risk factors for acquisition of multidrug-resistant Acinetobacter baumannii among cancer patients
- (2013) Yuriko Fukuta et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Colistin and Rifampicin Compared With Colistin Alone for the Treatment of Serious Infections Due to Extensively Drug-Resistant Acinetobacter baumannii: A Multicenter, Randomized Clinical Trial
- (2013) Emanuele Durante-Mangoni et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetic and Pharmacodynamic Issues for Antimicrobial Therapy in Patients With Cancer
- (2012) U. Theuretzbacher CLINICAL INFECTIOUS DISEASES
- Incidence of and Risk Factors for Colistin-Associated Nephrotoxicity in a Large Academic Health System
- (2011) J. M. Pogue et al. CLINICAL INFECTIOUS DISEASES
- Clinical characteristics and outcomes of bacteremia due to different genomic species of Acinetobacter baumannii complex in patients with solid tumors
- (2011) M.-C. Chiang et al. INFECTION
- Acinetobacter baumannii infection in patients with hematologic malignancies in intensive care unit: Risk factors and impact on mortality
- (2011) Melda Turkoglu et al. JOURNAL OF CRITICAL CARE
- Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia
- (2010) Antonio T. Freire et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Nephrotoxicity Associated with Intravenous Colistin (Colistimethate Sodium) Treatment at a Tertiary Care Medical Center
- (2009) Joshua D. Hartzell et al. CLINICAL INFECTIOUS DISEASES
- CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting
- (2008) Teresa C. Horan et al. AMERICAN JOURNAL OF INFECTION CONTROL
- Definition and Classification of Acute Kidney Injury
- (2008) John A. Kellum et al. NEPHRON CLINICAL PRACTICE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now